According to Nova One Advisor, the global gene editing market size is calculated at USD 11.29 billion in 2025 and is expected ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
News-Medical.Net on MSN
Researchers develop a versatile tool for controlling gene activity
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing ...
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR. This new solution brings ...
Morning Overview on MSN
Transparent squid could unlock big brain science breakthroughs
In a significant leap forward for neuroscience, researchers at the University of California, Santa Barbara, have successfully ...
Expanded Dose Exploration in Part A and Dose Escalation in Part B of BEAM-302 Phase 1/2 Study in Alpha-1 Antitrypsin Deficiency Ongoing; Updated ...
Advances 5x30 strategy by expanding pipeline with a highly complementary asset that has the potential to provide several days ...
Align Technology, Inc. , a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTerotm intraoral scanners, and exocadtm CAD/CAM ...
The global AI chip market has grown to $166.9 billion in 2025, and is predicted to reach $311.58 billion by 2029, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results